At 5.0% CAGR, the Middle East & Africa Bovine Diagnostics Market is projected to be worth US$ 67.91 million by 2030, says Business Market Insights

According to Business Market Insights’ research, the Middle East & Africa bovine diagnostics market was valued at US$ 46.03 million in 2022 and is expected to reach US$ 67.91 million by 2030, registering a CAGR of 5.0% from 2022 to 2030. High prevalence and economic impact of bovine mastitis and increasing number of product launches are among the critical factors attributed to the Middle East & Africa bovine diagnostics market expansion.       

Bovine mastitis is a global concern that incurs huge economic losses to the global agriculture sector. Mastitis results in lowered milk production in affected animals and causes continuous veterinary expenses, resulting in reduced profitability for dairy farmers. According to the estimates published by Thermo Fisher Scientific in July 2022, the total annual cost to the global dairy industry caused by mastitis is between US$ 19.7 million to US$ 32 million.

According to the study “Global and countrywide prevalence of subclinical and clinical mastitis in dairy cattle and buffaloes by systematic review and meta-analysis,” published in April 2021, the global pooled prevalence of subclinical mastitis (SCM) and clinical mastitis (CM) were 42% and 15%, respectively, during 2011–2019. The prevalence of mastitis is expected to increase due to the prolonged history of the disease in the dairy industry. The facts and data from across the world indicate the high prevalence of clinical mastitis, which triggers the demand for bovine diagnostics. Moreover, surveillance programs and good management systems introduced by governments in different countries support the bovine diagnostics market.

On the contrary, lack of skilled professionals in veterinary research hampers the Middle East & Africa bovine diagnostics market.

Based on product, the Middle East & Africa bovine diagnostics market is segmented into immunoassay kits, PCR reagents & kits, hemagglutination inhibition (HI) assay, and other products. The immunoassay kits segment held 45.0% share of Middle East & Africa bovine diagnostics market in 2022, amassing US$ 20.70 million. It is projected to garner US$ 31.75 million by 2030 to expand at 5.5% CAGR during 2022–2030.

Based on disease type, the Middle East & Africa bovine diagnostics market is segmented into bovine viral diarrhea (BVD), bovine tuberculosis (TB), bovine mastitis, foot and mouth disease (FMD), and other disease types. The bovine mastitis segment held 33.8% share of Middle East & Africa bovine diagnostics market in 2022, amassing US$ 15.56 million. It is projected to garner US$ 24.04 million by 2030 to expand at 5.6% CAGR during 2022–2030.

Based on end user, the Middle East & Africa bovine diagnostics market is segmented into veterinary hospitals, veterinary clinics, and other end-users. The veterinary hospitals segment held 48.6% share of Middle East & Africa bovine diagnostics market in 2022, amassing US$ 22.36 million. It is projected to garner US$ 34.82 million by 2030 to expand at 5.7% CAGR during 2022–2030.

Based on country, the Middle East & Africa bovine diagnostics market has been categorized into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 31.1% share of Middle East & Africa bovine diagnostics market in 2022. It was assessed at US$ 14.31 million in 2022 and is likely to hit US$ 19.95 million by 2030, exhibiting a CAGR of 4.2% during 2022–2030.

Key players operating in the Middle East & Africa bovine diagnostics market are bioMerieux SA, Idexx Laboratories Inc, Innovative Diagnostics SAS, and Thermo Fisher Scientific Inc, among others.   

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com